VISULAS 690 PLUS LASER & VISULINK PDT/U ADAPTER

System, Laser, Photodynamic Therapy

FDA Premarket Approval P990048 S003

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for changes to the laser controller; the addition of new user interface including touch-sensitieve screen and rotary knobs; a new integrated power supply with micro-controller electronic components; new labeling; and new software (firmware). The device, as modified, will be marketed under the trade name visulas 690plus and visulink pdt/u adapter and is indicated for use in visudyne therapy as sources of photoactivation of visudyne (verteporfin for injection) for the treatment of patients with predominantly classic subfoveal choroidal neovascularization due to macular degeneration, presumed ocular histoplasmosis or pathologic myopia.

DeviceVISULAS 690 PLUS LASER & VISULINK PDT/U ADAPTER
Classification NameSystem, Laser, Photodynamic Therapy
Generic NameSystem, Laser, Photodynamic Therapy
ApplicantCARL ZEISS MEDITEC AG
Date Received2008-04-22
Decision Date2008-10-31
PMAP990048
SupplementS003
Product CodeMVF
Advisory CommitteeGeneral & Plastic Surgery
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product Yes
Applicant Address CARL ZEISS MEDITEC AG 5160 Hacienda Drive dublin, CA 94568

Supplemental Filings

Supplement NumberDateSupplement Type
P990048Original Filing
S003 2008-04-22 Normal 180 Day Track
S002 2001-03-09 Normal 180 Day Track
S001 2000-08-14 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.